Welcome to RITUXAN
RITUXAN® (rituximab) is a prescription medicine used to treat Chronic Lymphocytic Leukemia (CLL)
Model on website does not depict actual patient.
*Eligibility criteria and annual limits apply. Not valid for patients using federal or state government programs to pay for their medications. Patients must be taking RITUXAN for an FDA-approved indication. See full TERMS AND CONDITIONS.
RITUXAN is available by prescription only.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.